Rocket Pharmaceuticals Inc (NASDAQ: RCKT) on Tuesday, plunged -0.98% from the previous trading day, before settling in for the closing price of $3.07. Within the past 52 weeks, RCKT’s price has moved between $2.19 and $22.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -11.60% over the last five years. The company achieved an average annual earnings per share of 22.42%. With a float of $99.07 million, this company’s outstanding shares have now reached $106.75 million.
The firm has a total of 299 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Rocket Pharmaceuticals Inc (RCKT) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Rocket Pharmaceuticals Inc is 8.05%, while institutional ownership is 86.38%. The most recent insider transaction that took place on Jul 03 ’25, was worth 4,257. In this transaction Chief Financial Officer of this company sold 1,477 shares at a rate of $2.88, taking the stock ownership to the 128,173 shares. Before that another transaction happened on Jul 03 ’25, when Company’s Officer proposed sale 1,477 for $2.88, making the entire transaction worth $4,256.
Rocket Pharmaceuticals Inc (RCKT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 22.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.04% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Rocket Pharmaceuticals Inc (RCKT) is currently performing well based on its current performance indicators. A quick ratio of 9.19 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.63, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.53 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
Analysing the last 5-days average volume posted by the [Rocket Pharmaceuticals Inc, RCKT], we can find that recorded value of 2.42 million was lower than the volume posted last year of 3.39 million. As of the previous 9 days, the stock’s Stochastic %D was 13.97%.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 12.69%, which indicates a significant decrease from 13.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was lower than the 0.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.98, while its 200-day Moving Average is $8.81.
